FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2093742457> ?p ?o ?g. }

• W2093742457 endingPage "882" @default.
• W2093742457 startingPage "872" @default.
• W2093742457 abstract "Lung cancer is the second most diagnosed cancer and the leading cause of cancer-related mortality in Canada. Surgical resection is the treatment of choice for patients with stage I non-small-cell lung cancer (NSCLC). However, 20% to 30% of them are deemed medically inoperable and may be offered radiation therapy. Standard external-beam radiation therapy (EBRT) is associated with high rates of local recurrence and poor long-term survival. Stereotactic ablative radiation therapy (SABR) is increasingly being proposed for inoperable patients, and the use of this treatment modality for operable patients is also being contemplated. The objective of this guideline is to review the efficacy and safety of SABR in these two clinical situations and to develop evidence-based recommendations.A review of the scientific literature published up to December 2013 was performed. A total of 44 publications were included.Considering the evidence available to date, the Comité de l'évolution des pratiques en oncologie recommends the following: (1) for medically operable patients with stage T1-2N0M0 NSCLC, surgery remains the standard treatment because comparative data regarding the efficacy of SABR and surgery are currently insufficient for SABR to be considered an equivalent alternative to surgery for these patients; (2) for medically inoperable patients with stage T1-2N0M0 NSCLC or medically operable patients who refuse surgery, SABR should be preferred to standard EBRT (grade B recommendation); (3) the biological equivalent dose (BED(10)) used for SABR treatment should be at least 100 Gy (grade B recommendation); (4) for patients with a central tumor, a large-volume tumor (large planning target volume) or severe pulmonary comorbidity, a risk-adaptive schedule should be used (dose reduction or increase in the number of fractions; grade B recommendation); (5) the choice of using SABR to treat NSCLC should be discussed within tumor boards; treatment with SABR (or with standard EBRT) should not be considered for patients whose life expectancy is very limited because of comorbidities (grade D recommendation)." @default.
• W2093742457 created "2016-06-24" @default.
• W2093742457 creator A5007038465 @default.
• W2093742457 creator A5016773298 @default.
• W2093742457 creator A5022977408 @default.
• W2093742457 creator A5023270374 @default.
• W2093742457 creator A5023286070 @default.
• W2093742457 creator A5055856172 @default.
• W2093742457 creator A5063012663 @default.
• W2093742457 creator A5090239249 @default.
• W2093742457 date "2015-06-01" @default.
• W2093742457 modified "2023-09-26" @default.
• W2093742457 title "Stereotactic Ablative Radiation Therapy for the Treatment of Early-stage Non–Small-Cell Lung Cancer: CEPO Review and Recommendations" @default.
• W2093742457 cites W1845262477 @default.
• W2093742457 cites W1965075076 @default.
• W2093742457 cites W1967821811 @default.
• W2093742457 cites W1969712381 @default.
• W2093742457 cites W1981692415 @default.
• W2093742457 cites W1981905971 @default.
• W2093742457 cites W1984747135 @default.
• W2093742457 cites W1988841675 @default.
• W2093742457 cites W1990840230 @default.
• W2093742457 cites W2003625414 @default.
• W2093742457 cites W2005842510 @default.
• W2093742457 cites W2008813541 @default.
• W2093742457 cites W2010285845 @default.
• W2093742457 cites W2013982338 @default.
• W2093742457 cites W2014291266 @default.
• W2093742457 cites W2019823097 @default.
• W2093742457 cites W2022396173 @default.
• W2093742457 cites W2022774277 @default.
• W2093742457 cites W2024107960 @default.
• W2093742457 cites W2030475888 @default.
• W2093742457 cites W2030755679 @default.
• W2093742457 cites W2036855640 @default.
• W2093742457 cites W2038905276 @default.
• W2093742457 cites W2043561789 @default.
• W2093742457 cites W2044021470 @default.
• W2093742457 cites W2049681888 @default.
• W2093742457 cites W2050748383 @default.
• W2093742457 cites W2051021899 @default.
• W2093742457 cites W2052630100 @default.
• W2093742457 cites W2056221208 @default.
• W2093742457 cites W2067940417 @default.
• W2093742457 cites W2076024434 @default.
• W2093742457 cites W2077960864 @default.
• W2093742457 cites W2078122354 @default.
• W2093742457 cites W2092014242 @default.
• W2093742457 cites W2099617715 @default.
• W2093742457 cites W2106893486 @default.
• W2093742457 cites W2112097252 @default.
• W2093742457 cites W2115646671 @default.
• W2093742457 cites W2118273634 @default.
• W2093742457 cites W2119462550 @default.
• W2093742457 cites W2120919324 @default.
• W2093742457 cites W2127426304 @default.
• W2093742457 cites W2139141356 @default.
• W2093742457 cites W2139494312 @default.
• W2093742457 cites W2141308797 @default.
• W2093742457 cites W2141938478 @default.
• W2093742457 cites W2155070439 @default.
• W2093742457 cites W2156415665 @default.
• W2093742457 cites W2157035821 @default.
• W2093742457 cites W2159746573 @default.
• W2093742457 cites W2163211182 @default.
• W2093742457 cites W2165808520 @default.
• W2093742457 cites W2166069569 @default.
• W2093742457 cites W2507737385 @default.
• W2093742457 cites W4249552602 @default.
• W2093742457 cites W4255820190 @default.
• W2093742457 cites W50507632 @default.
• W2093742457 doi "https://doi.org/10.1097/jto.0000000000000524" @default.
• W2093742457 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/26001140" @default.
• W2093742457 hasPublicationYear "2015" @default.
• W2093742457 type Work @default.
• W2093742457 sameAs 2093742457 @default.
• W2093742457 citedByCount "36" @default.
• W2093742457 countsByYear W20937424572015 @default.
• W2093742457 countsByYear W20937424572016 @default.
• W2093742457 countsByYear W20937424572017 @default.
• W2093742457 countsByYear W20937424572018 @default.
• W2093742457 countsByYear W20937424572019 @default.
• W2093742457 countsByYear W20937424572020 @default.
• W2093742457 countsByYear W20937424572021 @default.
• W2093742457 countsByYear W20937424572022 @default.
• W2093742457 countsByYear W20937424572023 @default.
• W2093742457 crossrefType "journal-article" @default.
• W2093742457 hasAuthorship W2093742457A5007038465 @default.
• W2093742457 hasAuthorship W2093742457A5016773298 @default.
• W2093742457 hasAuthorship W2093742457A5022977408 @default.
• W2093742457 hasAuthorship W2093742457A5023270374 @default.
• W2093742457 hasAuthorship W2093742457A5023286070 @default.
• W2093742457 hasAuthorship W2093742457A5055856172 @default.
• W2093742457 hasAuthorship W2093742457A5063012663 @default.
• W2093742457 hasAuthorship W2093742457A5090239249 @default.
• W2093742457 hasBestOaLocation W20937424571 @default.
• W2093742457 hasConcept C106159729 @default.
• W2093742457 hasConcept C121608353 @default.

• next